Group One Trading’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,560
Closed -$59.5K 7812
2023
Q2
$59.5K Sell
5,560
-240
-4% -$1.62K ﹤0.01% 5125
2023
Q1
$36.5K Buy
5,800
+5,670
+4,362% +$42.2K ﹤0.01% 5082
2022
Q4
$910 Sell
130
-20
-13% -$141 ﹤0.01% 6853
2022
Q3
$1K Buy
+150
New +$1.45K ﹤0.01% 7299
2021
Q4
Sell
-2,710
Closed -$72K 8365
2021
Q3
$72K Sell
2,710
-1,260
-32% -$36.8K ﹤0.01% 6230
2021
Q2
$136K Sell
3,970
-400
-9% -$15.7K ﹤0.01% 5641
2021
Q1
$220K Buy
+4,370
New +$270K ﹤0.01% 4926

Other funds holding EVGN

Group One Trading's EVGN Position: Q2 2024 in Review

Group One Trading sold out of Evogene (EVGN) in Q2 2024, closing a stake of 13 shares — an estimated $93 sold.

Group One Trading first reported a position in EVGN in Q1 2021 and held it in 11 quarters. The position peaked at $56K in Q1 2022. 28 funds tracked by Wall St. Rank hold EVGN as of Q2 2024.

  • Group One Trading reported no remaining Evogene position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 13 Evogene shares in Q2 2024, an estimated $93.
  • Group One Trading first reported a position in Evogene in Q1 2021 and held it in 11 quarters.
  • Group One Trading's Evogene position peaked at $56K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Evogene as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.